Department of Biostatistics and Translational Medicine
Project
We are pleased to inform you that the project ‘Radonek-AI – virtual assistant for oncological patients’ has been granted 70,000.00 PLN as part of the ‘Student Scientific Associations Creating Innovations’ initiative. The project will be carried out by members of the Student Scientific Association of Artificial Intelligence in Oncology, operating at the Department of Biostatistics […]
We are happy to announce that the miRPOC project (“miRPOC: miRNA as biomarkers in early detection and personalised treatment in ovarian cancer”) has been awarded funding under the ERA PerMed Joint Translational Call 2022, co-financed by the European Commission. This project is conducted within an international research consortium and aims to develop and validate a […]
We are pleased to announce that Ewelina Perdas, PhD, from our Department, has become one of the 114 laureates of the Bekker NAWA Program – Mieczysław Bekker Program! For one year, starting from May 2024, Dr. Perdas will collaborate with Prof. Theresa L. Whiteside at the UPMC Hillman Cancer Center at the University of Pittsburgh […]
In Poland, breast cancer poses an alarming health issue, affecting nearly 20,000 women annually. It is the second most common cause of cancer-related deaths, surpassed only by lung cancer. Ovarian cancer, although less common, is characterized by a very high mortality rate – 2,700 cases per year. One of the key factors increasing the risk […]
We are delighted to inform you that the clinical research project led by Dr Anna Matyjek, a nephrology specialist from our team, titled “B cell depletion therapy to improve outcomes of steroid-sensitive nephrotic syndrome in adults – the BOOSTER trial,” has received funding recommendation in the second edition of the Medical Research Agency’s Head-to-Head Research […]
Breast cancer is the most common cancer in women. In 2020, 2.3 million new cases were diagnosed, accounting for 11.7% of new cancer diagnoses worldwide. Approximately 5% – 10% of cases involve hereditary breast and ovarian cancer (HBOC), most commonly linked to mutations in the BRCA1 or BRCA2 genes. Currently, BRCA1/2 genetic tests are recommended […]
We are excited to share that Dr. Monika Anna Golińska has been awarded the NCN “MSCA POLONEZ BIS 3” grant for her project titled “ENDOVO: Identifying biomarkers in endometriosis-associated ovarian cancer using photoacoustic imaging and data mining.” The project will be conducted at the Department of Biostatistics and Translational Medicine. Endometriosis is a condition where […]
Obesity is one of the main risk factors for the development of type 2 diabetes as it leads to excessive production of free radicals, disruptions in glucose and fatty acid metabolism, and insulin resistance. The study focuses on understanding the role of the NUDT16L1 protein, which is a key regulator of TP53 activity. Deletion or […]
Type 1 diabetes (T1D) is the most common metabolic disease in childhood. It is caused by the destruction of pancreatic beta cells by one’s malfunctioning immune system. The lost beta cells are responsible for the production of insulin – an essential hormone in blood glucose levels regulation. Treatment of T1D demands life-long subcutaneous insulin supplementation […]
Transplantation of hematopoietic stem cells from bone marrow is a widely used method for treating various diseases, such as blood cancers, metabolic disorders, and autoimmune diseases. However, some patients are unable to undergo this procedure effectively due to problems with mobilizing an adequate number of stem cells. The study proposes to evaluate the role of […]
